ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
A Scalable Droplet Microfluidic Platform That Overcomes Large-Cell Constraints for Long-Term Plant Cell Culture and Embryogenesis Analysis.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Microspore-derived embryogenesis (MDE) is essential for doubled haploid (DH) plant breeding, but conventional bulk culture systems are limited by poor scalability and difficulty for automation. Adapting droplet microfluidics for plant cell culture is promising but challenging due to the large size and fragility of plant cells involved in embryogenesis, such as maize microspores (60-85 µm) and their expanding embryo-like structures (200-500 µm). Here, we present a droplet microfluidic platform engineered for large plant cells, integrating a tubing-based loading strategy that minimizes sedimentation losses, robust generation of stable 20 and 200 nL droplets optimized for large-cell encapsulation, and scalable 3D reservoir incubation for long-term culture. Optimized flow conditions and surface treatments enabled cell encapsulation with high fidelity, sustaining viability for over two weeks. Multi-modal viability assessment using fluorescence spectroscopy and microscopy (bright-field and fluorescence) confirmed that droplet culture preserves cell health comparably to bulk methods. The platform supports both single-cell and few-cell encapsulation modes, and increasing droplet volume and cell loading density further enhances embryogenesis rates and total embryo yield, respectively. Together, these advances establish a scalable, modular droplet microfluidic platform for high-throughput embryogenesis analysis and embryo production, offering new opportunities in plant developmental biology, precision breeding, and doubled-haploid technology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.